{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:15:59Z","timestamp":1791951359210,"version":"4.3.4"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH071916"],"award-info":[{"award-number":["MH071916"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veteran\u05f3s Administration VISN 22 Mental Illness Research, Education, and Clinical Center"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ejphar.2014.05.063","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T19:31:15Z","timestamp":1407267075000},"page":"114-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["The catecholaminergic\u2013cholinergic balance hypothesis of bipolar disorder revisited"],"prefix":"10.1016","volume":"753","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8344-7750","authenticated-orcid":false,"given":"Jordy","family":"van Enkhuizen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Janowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpi","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.05.063_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.biopsych.2011.01.018","article-title":"Trait-related decision-making impairment in the three phases of bipolar disorder","volume":"70","author":"Adida","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000106476","article-title":"A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls","volume":"55","author":"Amsterdam","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib3","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1176\/appi.ajp.157.7.1108","article-title":"Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients","volume":"157","author":"Anand","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib4","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0006-3223(98)00293-5","article-title":"Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder","volume":"45","author":"Anand","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1399-5618.2011.00936.x","article-title":"Striatal dopamine transporter availability in unmedicated bipolar disorder","volume":"13","author":"Anand","year":"2011","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ejphar.2014.05.063_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/YPG.0b013e32833a9b7a","article-title":"Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia","volume":"20","author":"Ancin","year":"2010","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.ejphar.2014.05.063_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbr.2008.08.016","article-title":"Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests","volume":"197","author":"Andreasen","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/FBP.0b013e32832c713e","article-title":"Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex","volume":"20","author":"Andreasen","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.pbb.2011.11.004","article-title":"Combined alpha7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987","volume":"100","author":"Andreasen","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.05.063_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/0269881108091587","article-title":"Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests","volume":"23","author":"Andreasen","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib11","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1177\/0269881110391831","article-title":"Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline","volume":"25","author":"Andreasen","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/phrs.2000.0672","article-title":"Decreased body temperature dependent appearance of behavioral despair in the forced swimming test in mice","volume":"42","author":"Arai","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajmg.b.20038","article-title":"Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression","volume":"123B","author":"Benedetti","year":"2003","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet.: Off. Publ. Int. Soc. Psychiatr. Genet."},{"key":"10.1016\/j.ejphar.2014.05.063_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","article-title":"Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder","author":"Berk","year":"2007","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.ejphar.2014.05.063_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00005053-196404000-00009","article-title":"Some behavioral changes in man following anticholinesterase administration","volume":"138","author":"Bowers","year":"1964","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.ejphar.2014.05.063_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0091-3057(96)00240-7","article-title":"High dose pimozide does not block amphetamine-induced euphoria in normal volunteers","volume":"56","author":"Brauer","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.05.063_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/cpt1971122part1218","article-title":"Catecholamines and mania: the effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism","volume":"12","author":"Brodie","year":"1971","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2014.05.063_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-1019521","article-title":"A second generation catecholamine hypothesis","volume":"15","author":"Bunney","year":"1982","journal-title":"Pharmacopsychiatria"},{"key":"10.1016\/j.ejphar.2014.05.063_bib19","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1176\/ajp.127.7.872","article-title":"Studies of alpha-methyl-para-tyrosine, l-dopa, and l-tryptophan in depression and mania","volume":"127","author":"Bunney","year":"1971","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/sj.npp.1300966","article-title":"Mice with chronically elevated dopamine exhibit enhanced motivation, but not learning, for a food reward","volume":"31","author":"Cagniard","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archpsyc.63.7.741","article-title":"Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder","volume":"63","author":"Cannon","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/mp.2010.24","article-title":"Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder","volume":"16","author":"Cannon","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00427135","article-title":"Mood alterations during deanol therapy","volume":"62","author":"Casey","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1399-5618.2009.00771.x","article-title":"Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1","volume":"12","author":"Chang","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ejphar.2014.05.063_bib25","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0278-5846(94)90115-5","article-title":"Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy","volume":"18","author":"Charles","year":"1994","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1096-8628(19960726)67:4<424::AID-AJMG21>3.0.CO;2-K","article-title":"Systematic screening for mutations in the 5\u2032-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder","volume":"67","author":"Cichon","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejphar.2014.05.063_bib27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ajmg.10406","article-title":"Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women","volume":"114","author":"Comings","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejphar.2014.05.063_bib28","author":"Cooper","year":"1991","journal-title":"Biochem. Basis Neuropharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib29","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/npp.2011.33","article-title":"Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the ClockDelta19 mouse model of mania","volume":"36","author":"Coque","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1399-5618.2009.00760.x","article-title":"The role of dopamine in bipolar disorder","volume":"11","author":"Cousins","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ejphar.2014.05.063_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2014.05.063_bib32","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbr.2010.02.023","article-title":"The cholinergic system and depression","volume":"221","author":"Dagyte","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/phrs.2000.0678","article-title":"Immobilization stress-induced changes in brain acetylcholinesterase activity and cognitive function in mice","volume":"42","author":"Das","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib34","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1176\/ajp.136.12.1581","article-title":"Choline chloride in schizophrenia","volume":"136","author":"Davis","year":"1979","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archpsyc.1978.01770250121012","article-title":"Physostigmine in mania","volume":"35","author":"Davis","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1176\/ajp.144.4.468","article-title":"Induction of depression with oxotremorine in patients with Alzheimer\u2019s disease","volume":"144","author":"Davis","year":"1987","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2009.09.040","article-title":"Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder","volume":"207","author":"Dencker","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib38","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1038\/tp.2013.74","article-title":"Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research","volume":"3","author":"Der-Avakian","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0091-3057(92)90053-I","article-title":"The Flinders sensitive line exhibits enhanced thermic responsiveness to nicotine relative to the Sprague-Dawley rat","volume":"41","author":"Dilsaver","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.05.063_bib40","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000090703","article-title":"Dopamine receptor D1 gene-48A\/G polymorphism is associated with bipolar illness but not with schizophrenia in a polish population","volume":"53","author":"Dmitrzak-Weglarz","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbr.2011.07.032","article-title":"The amphetamine\u2013chlordiazepoxide mixture, a pharmacological screen for mood stabilizers, does not enhance amphetamine-induced disruption of prepulse inhibition","volume":"225","author":"Douma","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib42","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biopsych.2009.11.021","article-title":"Replication of scopolamine\u2019s antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial","volume":"67","author":"Drevets","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib43","series-title":"Diagnostic and statistical manual of mental health disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.ejphar.2014.05.063_bib44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0006-3223(85)90043-5","article-title":"Cholinergic REM induction response: separation of anxiety and depression","volume":"20","author":"Dube","year":"1985","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/science.1234152","article-title":"Neurotransmitter switching in the adult brain regulates behavior","volume":"340","author":"Dulcis","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2014.05.063_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01300132","article-title":"The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment","volume":"40","author":"Dunstan","year":"1977","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2014.05.063_bib47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pbb.2006.01.006","article-title":"Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization","volume":"83","author":"Egashira","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.05.063_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1360-0443.1973.tb01264.x","article-title":"Induction of severe depression by physostigmine in marihuana intoxicated individuals","volume":"68","author":"El-Yousef","year":"1973","journal-title":"Br. J. Addict. Alcohol Other Drugs"},{"key":"10.1016\/j.ejphar.2014.05.063_bib49","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.neuroscience.2005.01.043","article-title":"Blunted response to cocaine in the Flinders hypercholinergic animal model of depression","volume":"132","author":"Fagergren","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2014.05.063_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002130000531","article-title":"Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression","volume":"152","author":"Ferguson","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib51","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/157016308785739848","article-title":"Advances in drug discovery to assess cholinergic neurotransmission: a systematic review","volume":"5","author":"Ferreira","year":"2008","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0269881105051525","article-title":"Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat","volume":"19","author":"Ferrie","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1017\/S1461145705006243","article-title":"Effect of lithium and lithium withdrawal on potassium-evoked dopamine release and tyrosine hydroxylase expression in the rat","volume":"9","author":"Ferrie","year":"2006","journal-title":"Int. J. Neuropsychopharmacol.: Off. Sci. J. Coll. Int. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib54","unstructured":"Frankel E., Drevets W., Luckenbaugh D., Speer A., Nugent A., Zarate C., Furey M., 2011. In: Proceedings of the 9th International Conference on Bipolar Disorder, Pittsburgh, PA, Poster P58."},{"key":"10.1016\/j.ejphar.2014.05.063_bib55","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial","volume":"63","author":"Furey","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib56","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/npp.2010.131","article-title":"Scopolamine produces larger antidepressant and antianxiety effects in women than in men","volume":"35","author":"Furey","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/appi.ajp.2011.11060940","article-title":"Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis","volume":"169","author":"Fusar-Poli","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib58","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1073\/pnas.191353298","article-title":"Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter","volume":"98","author":"Gainetdinov","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.05.063_bib59","series-title":"Bipolar Disorders: Basic Mechanisms and Therapeutic Implications","doi-asserted-by":"crossref","DOI":"10.3109\/9781420021158.003","article-title":"Abnormalities in catecholamines and the pathophysiology of bipolar disorder","author":"Garakani","year":"2007"},{"key":"10.1016\/j.ejphar.2014.05.063_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1527-3458.2004.tb00010.x","article-title":"TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects","volume":"10","author":"Gatto","year":"2004","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejphar.2014.05.063_bib61","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/JCP.0b013e318172b49e","article-title":"Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study","volume":"28","author":"George","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib62","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1176\/ajp.141.12.1533","article-title":"CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls","volume":"141","author":"Gerner","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib63","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(61)92004-9","article-title":"Psychiatric sequelae of chronic exposure to organophosphorus insecticides","volume":"1","author":"Gershon","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.05.063_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jad.2008.11.015","article-title":"Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects","volume":"116","author":"Gibbons","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2014.05.063_bib65","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2014.05.063_bib66","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.1990.03450120058029","article-title":"Smoking, smoking cessation, and major depression","volume":"264","author":"Glassman","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2014.05.063_bib67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.mp.4001032","article-title":"Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH\/NE states","volume":"7","author":"Gold","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib68","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0166-2236(90)90104-I","article-title":"Neurotransmitters and neuromodulators in the basal ganglia","volume":"13","author":"Graybiel","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2014.05.063_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/sj.mp.4001764","article-title":"Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples","volume":"11","author":"Greenwood","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1161>3.0.CO;2-8","article-title":"Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder","volume":"105","author":"Greenwood","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejphar.2014.05.063_bib71","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.pharmtox.47.120505.105242","article-title":"The functional impact of SLC6 transporter genetic variation","volume":"47","author":"Hahn","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib72","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2010.03.011","article-title":"Effect of the use-dependent, nicotinic receptor antagonist BTMPS in the forced swim test and elevated plus maze after cocaine discontinuation in rats","volume":"474","author":"Hall","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2014.05.063_bib73","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-6-6","article-title":"Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs","volume":"6","author":"Han","year":"2006","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2013.04.004","article-title":"Changes in the cholinergic system between bipolar depression and euthymia as measured with [I]5IA single photon emission computed tomography","author":"Hannestad","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0006-3223(91)90041-J","article-title":"The cholinergic-adrenergic hypothesis of depression reexamined using clonidine, metoprolol, and physostigmine in an animal model","volume":"29","author":"Hasey","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biopsych.2005.11.006","article-title":"Toward constructing an endophenotype strategy for bipolar disorders","volume":"60","author":"Hasler","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib77","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neubiorev.2010.04.002","article-title":"Cross-species assessments of motor and exploratory behavior related to bipolar disorder","volume":"34","author":"Henry","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2014.05.063_bib78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2003.10.043","article-title":"Association study of the human partially duplicated alpha7 nicotinic acetylcholine receptor genetic variant with bipolar disorder","volume":"355","author":"Hong","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2014.05.063_bib79","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.mp.4001730","article-title":"A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression","volume":"10","author":"Horschitz","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib80","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1017\/S0033291700009132","article-title":"Dextroamphetamine-induced arousal in human subjects as a model for mania","volume":"16","author":"Jacobs","year":"1986","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ejphar.2014.05.063_bib81","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11920-011-0239-6","article-title":"Serendipity strikes again: scopolamine as an antidepressant agent in bipolar depressed patients","volume":"13","author":"Janowsky","year":"2011","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.ejphar.2014.05.063_bib82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00006842-197405000-00008","article-title":"Acetylcholine and depression","volume":"36","author":"Janowsky","year":"1974","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.ejphar.2014.05.063_bib83","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ajmg.1320540412","article-title":"Is cholinergic sensitivity a genetic marker for the affective disorders?","volume":"54","author":"Janowsky","year":"1994","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejphar.2014.05.063_bib84","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic-adrenergic hypothesis of mania and depression","volume":"2","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.05.063_bib85","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1176\/ajp.130.12.1370","article-title":"Antagonistic effects of physostigmine and methylphenidate in man","volume":"130","author":"Janowsky","year":"1973","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib86","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpsyc.1973.01750340072012","article-title":"Parasympathetic suppression of manic symptoms by physostigmine","volume":"28","author":"Janowsky","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib87","first-page":"29","article-title":"Increased vulnerability to cholinergic stimulation in affective-disorder patients [proceedings]","volume":"16","author":"Janowsky","year":"1980","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.ejphar.2014.05.063_bib88","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00310619","article-title":"Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release","volume":"89","author":"Janowsky","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib89","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/(SICI)1096-8628(19961122)67:6<533::AID-AJMG4>3.0.CO;2-I","article-title":"Possible locus for bipolar disorder near the dopamine transporter on chromosome 5","volume":"67","author":"Kelsoe","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejphar.2014.05.063_bib90","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4088\/JCP.12m07706","article-title":"Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study","volume":"73","author":"Khajavi","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib91","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00702-012-0783-1","article-title":"Effects of morning compared with evening bright light administration to ameliorate short-photoperiod induced depression- and anxiety-like behaviors in a diurnal rodent model","volume":"119","author":"Krivisky","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2014.05.063_bib92","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2010.02.029","article-title":"Strain and regional dependence of alternate splicing of acetylcholinesterase in the murine brain following stress or treatment with diisopropylfluorophosphate","volume":"210","author":"Livneh","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib93","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.psychres.2005.04.004","article-title":"No association between common variations in the neuronal nicotinic acetylcholine receptor alpha2 subunit gene (CHRNA2) and bipolar I disorder","volume":"135","author":"Lohoff","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib94","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF02246266","article-title":"Euphorigenic doses of cocaine reduce [123I]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts","volume":"122","author":"Malison","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib95","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1242\/dmm.001628","article-title":"Reverse translational strategies for developing animal models of bipolar disorder","volume":"2","author":"Malkesman","year":"2009","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.ejphar.2014.05.063_bib96","first-page":"136","article-title":"The underlying neurobiology of bipolar disorder","volume":"2","author":"Manji","year":"2003","journal-title":"World Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib97","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0197-0186(98)00028-X","article-title":"Effects of lithium, alone or associated with pilocarpine, on muscarinic and dopaminergic receptors and on phosphoinositide metabolism in rat hippocampus and striatum","volume":"33","author":"Marinho","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2014.05.063_bib98","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.physbeh.2011.04.052","article-title":"Cholinergic modulation of mesolimbic dopamine function and reward","volume":"104","author":"Mark","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2014.05.063_bib99","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10298420290023963","article-title":"Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories","volume":"4","author":"Markou","year":"2002","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0893-133X(97)00113-9","article-title":"Neurobiological similarities in depression and drug dependence: a self-medication hypothesis","volume":"18","author":"Markou","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib101","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0006-3223(94)91177-0","article-title":"Flinders resistant hypocholinergic rats exhibit startle sensitization and reduced startle thresholds","volume":"36","author":"Markou","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib102","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S1461145709991143","article-title":"Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania","volume":"13","author":"Mavrikaki","year":"2010","journal-title":"Int. J. Neuropsychopharmacol.: Off. Sci. J. Coll. Int. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib103","doi-asserted-by":"crossref","first-page":"9377","DOI":"10.1073\/pnas.0503584102","article-title":"Regulation of dopaminergic transmission and cocaine reward by the Clock gene","volume":"102","author":"McClung","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.05.063_bib104","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bcp.2013.06.016","article-title":"Animal models of CNS disorders","volume":"87","author":"McGonigle","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s002130050823","article-title":"Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release","volume":"141","author":"McTavish","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib106","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/026988119901300205","article-title":"Attenuation of some subjective effects of amphetamine following tyrosine depletion","volume":"13","author":"McTavish","year":"1999","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib107","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1192\/bjp.179.4.356","article-title":"Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness","volume":"179","author":"McTavish","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib108","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib109","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0165-1781(85)90121-0","article-title":"Methylphenidate infusion in euthymic bipolars: effect of carbamazepine pretreatment","volume":"16","author":"Meyendorff","year":"1985","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib110","first-page":"109","article-title":"Associations between COMTValMet genotype and clinical and cognitive phenotypes in manic bipolar patients","volume":"35","author":"Minassian","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ejphar.2014.05.063_bib111","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neuropharm.2007.01.006","article-title":"Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL\/6J mice","volume":"52","author":"Mineur","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib112","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1073\/pnas.1219731110","article-title":"Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior","volume":"110","author":"Mineur","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.05.063_bib113","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0028-1094395","article-title":"[Investigation about an influence of physostigmine on schizophrenic symptoms (author\u2019s transl)]","volume":"6","author":"Modestin","year":"1973","journal-title":"Pharmakopsychiatr. Neuropsychopharmakol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00347089","article-title":"[Depressive effects of physostigmine]","volume":"218","author":"Modestin","year":"1973","journal-title":"Arch. Psychiatr. Nervenkrankh."},{"key":"10.1016\/j.ejphar.2014.05.063_bib115","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0006-3223(02)01433-6","article-title":"Linkage disequilibrium between dopamine D1 receptor gene (DRD1) and bipolar disorder","volume":"52","author":"Ni","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib116","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1176\/ajp.149.2.199","article-title":"Lack of association between dopamine D1 and D2 receptor genes and bipolar affective disorder","volume":"149","author":"Nothen","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-5618.2009.00786.x","article-title":"Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence","volume":"12","author":"Novick","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ejphar.2014.05.063_bib118","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-1781(83)90043-4","article-title":"Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and \u201cwell state\u201d bipolar patients","volume":"9","author":"Nurnberger","year":"1983","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib119","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0022-3956(79)90024-4","article-title":"Effect of lithium on the physostigmine-induced behavioral syndrome and plasma cyclic GMP","volume":"15","author":"Oppenheim","year":"1979","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib120","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/0006-3223(94)00250-7","article-title":"The WAGxDA rat: an animal model of cholinergic supersensitivity","volume":"37","author":"Orpen","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib121","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archpsyc.58.9.844","article-title":"Excess mortality in bipolar and unipolar disorder in Sweden","volume":"58","author":"Osby","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib122","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0149-7634(05)80230-1","article-title":"The Flinders sensitive line rats: a genetic animal model of depression","volume":"17","author":"Overstreet","year":"1993","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2014.05.063_bib123","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1995.03950180057008","article-title":"In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder","volume":"52","author":"Pearlson","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib124","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2165\/00002018-199512020-00007","article-title":"Drug-induced mania","volume":"12","author":"Peet","year":"1995","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejphar.2014.05.063_bib125","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archgenpsychiatry.2009.58","article-title":"A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men","volume":"66","author":"Perry","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib126","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib127","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/npp.2011.45","article-title":"Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder","volume":"36","author":"Pinsonneault","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib128","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/FBP.0b013e32830dc110","article-title":"Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice","volume":"19","author":"Powell","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib129","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-006-0568-z","article-title":"The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice","volume":"189","author":"Rabenstein","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0006-3223(02)01489-0","article-title":"Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system","volume":"53","author":"Ralph-Williams","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib131","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1523\/JNEUROSCI.21-01-00305.2001","article-title":"Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists","volume":"21","author":"Ralph","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.05.063_bib132","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2011.08.017","article-title":"Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients","volume":"136","author":"Rao","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2014.05.063_bib133","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(81)90012-3","article-title":"Physostigmine induction of depressive symptomatology in normal human subjects","volume":"4","author":"Risch","year":"1981","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib134","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.biopsych.2009.04.008","article-title":"Risk-prone individuals prefer the wrong options on a rat version of the Iowa Gambling Task","volume":"66","author":"Rivalan","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2009.01.002","article-title":"Varenicline has antidepressant-like activity in the forced swim test and augments sertraline\u2019s effect","volume":"605","author":"Rollema","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib136","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-014-3472-y","article-title":"The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice","author":"Roni","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib137","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/jnnp.13.1.47","article-title":"The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis","volume":"13","author":"Rowntree","year":"1950","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib138","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1073\/pnas.0609625104","article-title":"Mania-like behavior induced by disruption of CLOCK","volume":"104","author":"Roybal","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2014.05.063_bib139","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4088\/JCP.v69n0816","article-title":"The use of antidepressants in bipolar disorder","volume":"69","author":"Salvi","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1176\/appi.ajp.2012.11101546","article-title":"Persistent beta2\u204e-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder","volume":"169","author":"Saricicek","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib141","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ajmg.b.20053","article-title":"Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism","volume":"121B","author":"Serretti","year":"2003","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet.: Off. Publ. Int. Soc. Psychiatr. Genet."},{"key":"10.1016\/j.ejphar.2014.05.063_bib142","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s007020200035","article-title":"Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder","volume":"109","author":"Shaldubina","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2014.05.063_bib143","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mehy.2011.10.005","article-title":"Evolutionary origin of bipolar disorder-revised: EOBD-R","volume":"78","author":"Sherman","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2014.05.063_bib144","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3223(00)00945-8","article-title":"Comorbid bipolar disorder in Tourette\u2019s syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine)","volume":"48","author":"Shytle","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.mp.4001035","article-title":"Nicotinic acetylcholine receptors as targets for antidepressants","volume":"7","author":"Shytle","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib146","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0165-1781(98)00037-7","article-title":"Lithium does not attenuate the effects of d-amphetamine in healthy volunteers","volume":"79","author":"Silverstone","year":"1998","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib147","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(84)91359-X","article-title":"Response to bromocriptine distinguishes bipolar from unipolar depression","volume":"1","author":"Silverstone","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.05.063_bib148","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0028-3908(80)90215-4","article-title":"The effect of the dopamine receptor blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine in man","volume":"19","author":"Silverstone","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib149","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0022-3956(87)90097-5","article-title":"The association of supersensitive cholinergic REM-induction and affective illness within pedigrees","volume":"21","author":"Sitaram","year":"1987","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib150","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00561141","article-title":"5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis","volume":"4","author":"Sjostrom","year":"1972","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib151","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1471-4159.2012.07857.x","article-title":"A mutation in CLOCK leads to altered dopamine receptor function","volume":"123","author":"Spencer","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2014.05.063_bib152","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.neuroscience.2006.08.041","article-title":"The involvement of cholinergic and noradrenergic systems in behavioral recovery following oxotremorine treatment to chronically stressed rats","volume":"143","author":"Srikumar","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2014.05.063_bib153","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0006-3223(00)00942-2","article-title":"Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy","volume":"48","author":"Steingard","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib154","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0006-8993(75)90433-3","article-title":"Role of biogenic amines in certain pathological conditions","volume":"87","author":"Subrahmanyam","year":"1975","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF02253582","article-title":"D1 dopamine receptor binding in mood disorders measured by positron emission tomography","volume":"106","author":"Suhara","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib156","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1023\/A:1026606201069","article-title":"Restraint stress-induced alterations in the levels of biogenic amines, amino acids, and AChE activity in the hippocampus","volume":"25","author":"Sunanda","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib157","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbr.2013.04.023","article-title":"Further evidence for ClockDelta19 mice as a model for bipolar disorder mania using cross-species tests of exploration and sensorimotor gating","volume":"249","author":"van Enkhuizen","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib158","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00213-012-2854-2","article-title":"Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania","volume":"225","author":"van Enkhuizen","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib159","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1017\/S1461145712001198","article-title":"Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice","volume":"16","author":"van Enkhuizen","year":"2013","journal-title":"Int. J. Neuropsychopharmacol.: Off. Sci. J. Coll. Int. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2013.08.041","article-title":"Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder","volume":"155","author":"van Enkhuizen","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2014.05.063_bib161","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00428897","article-title":"Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment","volume":"44","author":"Van Kammen","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.ejphar.2014.05.063_bib162","article-title":"Evaluation of acetylcholinesterase in an animal model of mania induced by d-amphetamine","author":"Varela","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2014.05.063_bib163","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states","volume":"34","author":"Vaughan","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2014.05.063_bib164","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0006-3223(00)00978-1","article-title":"Neuropathology of bipolar disorder","volume":"48","author":"Vawter","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.pra.0000432600.32384.c5","article-title":"Evidence for seasonal mania: a review","volume":"19","author":"Wang","year":"2013","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.ejphar.2014.05.063_bib166","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/j.1460-9568.2007.05460.x","article-title":"Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.05.063_bib167","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/hmg\/ddh194","article-title":"Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome","volume":"13","author":"Wang","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2014.05.063_bib168","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00004647-199703000-00010","article-title":"Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness","volume":"17","author":"Wong","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2014.05.063_bib169","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1176\/appi.ajp.159.10.1718","article-title":"PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania","volume":"159","author":"Yatham","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/7854_2010_62","article-title":"Animal models of schizophrenia","volume":"4","author":"Young","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2014.05.063_bib171","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1476-5381.2011.01318.x","article-title":"Predictive animal models of mania: hits, misses and future directions","volume":"164","author":"Young","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib172","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/0269881111400646","article-title":"Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania","volume":"25","author":"Young","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2014.05.063_bib173","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2010.03.014","article-title":"The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration","volume":"96","author":"Young","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.05.063_bib174","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-009-1744-8","article-title":"GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior","volume":"208","author":"Young","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2014.05.063_bib175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biopsych.2004.03.013","article-title":"Pramipexole for bipolar II depression: a placebo-controlled proof of concept study","volume":"56","author":"Zarate","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2014.05.063_bib176","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.brainresbull.2005.02.007","article-title":"M2\/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders","volume":"65","author":"Zavitsanou","year":"2005","journal-title":"Brain Res. Bull."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914005858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914005858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T12:05:24Z","timestamp":1565697924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914005858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":176,"alternative-id":["S0014299914005858"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.05.063","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The catecholaminergic\u2013cholinergic balance hypothesis of bipolar disorder revisited","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}